list of semaglutides Comparing Ozempic, Wegovy and Other GLP-1 Drugs Novo Nordisk medicines containing semaglutide

Skin The skin around the breasts is especially prone to stretching, and can lose its youthful elasticity once the fat beneath it has reduced, leaving looser, less supportive skin behind

As part of the membership, Healthspan helps coordinate prescriptions, refills, and medication logistics as treatment evolves

You can also use the BeSafeRx tool to check if the pharmacy is licensed

FDA-approved pharmacotherapy alternatives include several options with established safety profiles: Semaglutide (Wegovy): A GLP-1 receptor agonist producing 12-15% weight loss, with cardiovascular benefits demonstrated in the SELECT trial and FDA-approved indication for reducing cardiovascular risk Liraglutide (Saxenda): A GLP-1 receptor agonist producing 5-8% weight loss [4] Phentermine-topiramate (Qsymia): FDA-approved combination producing 7-10% weight loss with established safety data Naltrexone-bupropion (Contrave): Combination targeting reward pathways and appetite, producing 5-9% weight loss [4] Orlistat (Xenical, Alli): Lipase inhibitor producing 3-5% weight loss with gastrointestinal side effects [4] Setmelanotide (Imcivree): For rare genetic obesity disorders (POMC, PCSK1, LEPR deficiency) [4] Metabolic and bariatric surgery should be considered for patients with BMI 40 kg/m or 35 kg/m with obesity-related comorbidities who have not achieved adequate weight loss with nonsurgical interventions

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, but the time of day you inject may affect how well you tolerate the medication and achieve your weight loss goals

In the Phase 2 trial (Jastreboff et al., 2023), retatrutide was administered via subcutaneous injection once weekly